O'Day Daniel Patrick 4
4 · GILEAD SCIENCES, INC. · Filed Mar 12, 2026
Research Summary
AI-generated summary of this filing
Gilead (GILD) CEO Daniel O'Day Exercises Options, Sells Shares
What Happened
- Daniel Patrick O'Day (Chairman & CEO, Director) executed option-related transactions on 2026-03-10: he exercised options covering 20,026 shares and was granted restricted stock units (RSUs) of 32,815 and 122,755 shares (total RSUs granted = 155,570). To satisfy tax withholding, 9,767 shares were surrendered/disposed at $148.56 per share for proceeds (value) of $1,450,986. The filings show derivative activity associated with the option exercise and RSU grants.
Key Details
- Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (appears timely).
- Option exercise: 20,026 shares (code M — exercise/conversion of derivative).
- RSU grants: 32,815 shares (code A) and 122,755 shares at $0.00 (code A) — total 155,570 RSUs granted.
- Tax/withholding disposition: 9,767 shares disposed (code F) at $148.56 = $1,450,986 (used to cover taxes/exercise price).
- Shares owned after the transaction: not specified in the Form 4 provided.
- Footnotes: F1 — each RSU converts to one share on vesting; F2 — RSUs vest over four years (25% after one year, then 6.25% quarterly); F3 — stock options vest over four years with similar schedule.
Context
- The pattern (exercise of options coupled with a share disposition labeled F) is consistent with a cashless exercise or withholding of shares to satisfy tax obligations rather than an open-market sale for cash. RSU grants and option exercises are common executive compensation events and do not by themselves indicate a change in insider sentiment.
Insider Transaction Report
Form 4
O'Day Daniel Patrick
DirectorChairman & CEO
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-03-10+20,026→ 662,334 total - Tax Payment
Common Stock
2026-03-10$148.56/sh−9,767$1,450,986→ 652,567 total - Exercise/Conversion
Restricted Stock Unit
[F1][F2]2026-03-10−20,026→ 68,044 total→ Common Stock (20,026 underlying) - Award
Restricted Stock Unit
[F1][F2]2026-03-10+32,815→ 100,859 total→ Common Stock (32,815 underlying) - Award
Non-qualified Stock Option (Right to Buy)
[F3]2026-03-10+122,755→ 122,755 totalExercise: $148.56Exp: 2036-03-10→ Common Stock (122,755 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
- [F3]The stock options have a four-year vesting schedule. 25% of the options vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Signature
/s/ Amy Kim by Power of Attorney for Daniel O'Day|2026-03-12